Get started
GLENMARK LIFE SCIENCE LTDGLENMARK LIFE SCIENCE LTDGLENMARK LIFE SCIENCE LTD

GLENMARK LIFE SCIENCE LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

GLS chart


Full chart

GLS upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪120.92 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
28.50
Basic EPS (TTM)
34.55 INR
Net income (FY)
‪4.71 B‬ INR
Revenue (FY)
‪22.70 B‬ INR
Shares float
‪30.64 M‬
Beta (1Y)
−0.04

Employees


Employees (FY)
‪3.47 K‬
Change (1Y)
+184 +5.60%
Revenue / Employee (1Y)
‪6.54 M‬ INR
Net income / Employee (1Y)
‪1.36 M‬ INR

About GLENMARK LIFE SCIENCE LTD


Sector
Health Technology
CEO
Yasir Rawjee
Headquarters
Mumbai
Website
glenmarklifesciences.com
Founded
2011
ISIN
INE03Q201024
FIGI
BBG011WT9KP6
Alivus Life Sciences Ltd. engages in the provision of development and manufacture of non-commoditized active pharmaceutical ingredients. It operates through the Within India and Outside India geographical segments. Its products focus on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company was founded on June 23, 2011 and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GLS news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of GLS is 969.65 INR — it has increased by 0.39% in the past 24 hours. Watch GLENMARK LIFE SCIENCE LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange GLENMARK LIFE SCIENCE LTD stocks are traded under the ticker GLS.
GLS stock has fallen by −2.91% compared to the previous week, the month change is a −7.55% fall, over the last year GLENMARK LIFE SCIENCE LTD has showed a 48.26% increase.
We've gathered analysts' opinions on GLENMARK LIFE SCIENCE LTD future price: according to them, GLS price has a max estimate of 1,200.00 INR and a min estimate of 1,015.00 INR. Watch GLS chart and read a more detailed GLENMARK LIFE SCIENCE LTD stock forecast: see what analysts think of GLENMARK LIFE SCIENCE LTD and suggest that you do with its stocks.
GLS reached its all-time high on Sep 16, 2024 with the price of 1,335.10 INR, and its all-time low was 370.00 INR and was reached on Sep 28, 2022. View more price dynamics on GLS chart.
See other stocks reaching their highest and lowest prices.
GLS stock is 2.92% volatile and has beta coefficient of −0.04. Track GLENMARK LIFE SCIENCE LTD stock price on the chart and check out the list of the most volatile stocks — is GLENMARK LIFE SCIENCE LTD there?
Today GLENMARK LIFE SCIENCE LTD has the market capitalization of ‪118.69 B‬, it has decreased by −6.26% over the last week.
Yes, you can track GLENMARK LIFE SCIENCE LTD financials in yearly and quarterly reports right on TradingView.
GLENMARK LIFE SCIENCE LTD is going to release the next earnings report on Jan 23, 2025. Keep track of upcoming events with our Earnings Calendar.
GLS net income for the last quarter is ‪953.16 M‬ INR, while the quarter before that showed ‪1.11 B‬ INR of net income which accounts for −14.50% change. Track more GLENMARK LIFE SCIENCE LTD financial stats to get the full picture.
GLENMARK LIFE SCIENCE LTD dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 11.11% and 114.14% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 30, 2024, the company has ‪3.47 K‬ employees. See our rating of the largest employees — is GLENMARK LIFE SCIENCE LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLENMARK LIFE SCIENCE LTD EBITDA is ‪6.08 B‬ INR, and current EBITDA margin is 29.67%. See more stats in GLENMARK LIFE SCIENCE LTD financial statements.
Like other stocks, GLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLENMARK LIFE SCIENCE LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLENMARK LIFE SCIENCE LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLENMARK LIFE SCIENCE LTD stock shows the buy signal. See more of GLENMARK LIFE SCIENCE LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.